Maciej Cabanski

767 total citations
9 papers, 316 citations indexed

About

Maciej Cabanski is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Maciej Cabanski has authored 9 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Maciej Cabanski's work include Salivary Gland Disorders and Functions (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Maciej Cabanski is often cited by papers focused on Salivary Gland Disorders and Functions (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Maciej Cabanski collaborates with scholars based in Switzerland, United States and Germany. Maciej Cabanski's co-authors include Ewa Surdziel, Arnold Ganser, Thomas Dörner, Matthias Eder, Iris Dallmann, Marcin Łyszkiewicz, Michaela Scherr, Andreas Krueger, Maximilian Posch and Stephen J. Oliver and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and Toxicology Letters.

In The Last Decade

Maciej Cabanski

9 papers receiving 311 citations

Peers

Countries citing papers authored by Maciej Cabanski

Since Specialization

Citations

This map shows the geographic impact of Maciej Cabanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Cabanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Cabanski more than expected).

Fields of papers citing papers by Maciej Cabanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Cabanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Cabanski. The network helps show where Maciej Cabanski may publish in the future.

Co-authorship network of co-authors of Maciej Cabanski

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Cabanski. A scholar is included among the top collaborators of Maciej Cabanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Cabanski. Maciej Cabanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Possible alternative strategies to implement basophil activation testing in multicentric studies 2024 ·Cytometry Part B Clinical Cytometry ·(unknown), (unknown), (unknown), A. Carsin, (unknown), Maciej Cabanski, Alessandra Vitaliti, Jean‐Marc Busnel	2
2	Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial 2021 ·Clinical and Translational Science ·Martin Kaul, Peter End, Maciej Cabanski, (unknown), Annamária Jakab, Magdalena Kistowska, Arvind G. Kinhikar, Alessio Maiolica, (unknown), Rainard Fuhr, Bruno Cenni	59
3	Flow cytometric method transfer: Recommendations for best practice 2020 ·Cytometry Part B Clinical Cytometry ·Maciej Cabanski, Teri Oldaker, Jennifer J. Stewart, Nithianandan Selliah, (unknown), Cherie Green, Virginia Litwin, Alessandra Vitaliti	10
4	Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity 2019 ·Annals of the Rheumatic Diseases ·Thomas Dörner, Maximilian Posch, Yue Li, Olivier Pétricoul, Maciej Cabanski, Julie Milojevic, (unknown), Marie‐Anne Valentin, (unknown), Louise Mooney, Andreas Hüser, Hermann Gram, Frank Wagner, Stephen J. Oliver	126
5	OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome 2018 ·Annals of the Rheumatic Diseases ·Thomas Dörner, Margit Zeher, Ute Laessing, Frédérique Chaperon, Stefan Buck, (unknown), (unknown), Shuren Ma, Maciej Cabanski, Christoph Kalis, Christoph Burkhart, P Gergely	15
6	Safety and Efficacy of Long Term Suppression of PI3Kinase Pathway By Small Molecule PI3K-Delta Inhibitor, Leniolisib in Apds (Activated PI3Kδ Syndrome) 2018 ·Blood ·V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm, Anna Šedivá, P. Martin van Hagen, (unknown), Les Folio, Maciej Cabanski, Marie‐Anne Valentin, Stefan Buck, Christoph Kalis, (unknown), Christoph Burkhart, Klaus Kucher, (unknown), Gülbû Uzel	6
7	An application of 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product 2016 ·Toxicology Letters ·Anita R. Iskandar, Carole Mathis, Florian Martin, Patrice Leroy, Alain Sewer, Shoaib Majeed, (unknown), Keyur Trivedi, (unknown), Maciej Cabanski, Emmanuel Guedj, Céline Merg, Stefan Frentzel, Nikolai V. Ivanov, Manuel C. Peitsch, Julia Hoeng	2
8	Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains 2015 ·Inflammation Research ·Maciej Cabanski, (unknown), Stéphanie Boué, (unknown), Héctor De León, (unknown), Marcel Geertz, Emmanuel Guedj, Anita R. Iskandar, Ulrike Kogel, Céline Merg, Michael J. Peck, Carine Poussin, Walter K. Schlage, Marja Talikka, Nikolai V. Ivanov, Julia Hoeng, Manuel C. Peitsch	16
9	Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways 2011 ·Blood ·Ewa Surdziel, Maciej Cabanski, Iris Dallmann, Marcin Łyszkiewicz, Andreas Krueger, Arnold Ganser, Michaela Scherr, Matthias Eder	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact